La bourse ferme dans 2 h 15 min
  • CAC 40

    6 179,93
    +10,52 (+0,17 %)
     
  • Euro Stoxx 50

    3 975,73
    -3,11 (-0,08 %)
     
  • Dow Jones

    33 800,60
    +297,00 (+0,89 %)
     
  • EUR/USD

    1,1919
    +0,0014 (+0,12 %)
     
  • Gold future

    1 739,20
    -5,60 (-0,32 %)
     
  • BTC-EUR

    50 908,47
    +487,79 (+0,97 %)
     
  • CMC Crypto 200

    1 294,07
    +66,53 (+5,42 %)
     
  • Pétrole WTI

    60,47
    +1,15 (+1,94 %)
     
  • DAX

    15 253,30
    +19,14 (+0,13 %)
     
  • FTSE 100

    6 898,46
    -17,29 (-0,25 %)
     
  • Nasdaq

    13 900,19
    +70,89 (+0,51 %)
     
  • S&P 500

    4 128,80
    +31,63 (+0,77 %)
     
  • Nikkei 225

    29 538,73
    -229,33 (-0,77 %)
     
  • HANG SENG

    28 453,28
    -245,52 (-0,86 %)
     
  • GBP/USD

    1,3753
    +0,0048 (+0,35 %)
     

Psoriasis - Competitive Landscape in 2020

ReportLinker
·2 min de lecture

Summary "Psoriasis - Competitive Landscape in 2020" combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

New York, March 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Psoriasis - Competitive Landscape in 2020" - https://www.reportlinker.com/p06035014/?utm_source=GNW


Interleukin and tumor necrosis factor inhibitors are the major focus of drug developers.There are 350 drugs in the pipeline, 89% 0f which are in early-stage.

Big pharma dominates R&D in this indication. Addition of several high-priced therapies are expected to drive the market growth, but emergence of biosimilars to all the marketed brands is expected to act as a strong barrier to market growth.

This reports provides a data-driven overview of the current and future competitive landscape in Psoriasis therapeutics.

Scope
Components of the report include -
- Disease epidemiology
- Marketed drugs assessment
- Pipeline drugs assessment
- Clinical trials assessment
- Commercial assessment
- Social media overview
- Digital marketing overview

Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global psoriasis market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global psoriasis in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Read the full report: https://www.reportlinker.com/p06035014/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001